Core Laboratories (CLB) vs RPC (RES)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
RPC (RES) has outperformed Core Laboratories (CLB) over the past year, losing 8.4% versus a loss of 47.3%. Over five years, RES leads with a +15.9% price change compared with -67.9% for CLB. RPC is the larger company by market cap ($1.07 billion vs $355.6 million), about 3.0 times the size.
On valuation, Core Laboratories trades at a lower forward P/E (11.2x vs 15.3x for RPC). RPC offers the higher dividend yield (3.32% vs 0.52%). Core Laboratories converts more of its revenue into profit, with a net margin of 5.6% versus 2.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLB | RES |
|---|---|---|
| Share price | $7.76 | $4.82 |
| Market cap | $355.59M | $1.07B |
| 1-day change | -7.62% | -4.74% |
| YTD return | -51.59% | -11.40% |
| 1-year return | -47.28% | -8.37% |
| 5-year return | -67.85% | +15.87% |
| P/E ratio (TTM) | 22.82 | — |
| Forward P/E | 11.25 | 15.30 |
| EPS (TTM) | $0.34 | $-0.15 |
| Dividend yield | 0.52% | 3.32% |
| Annual dividend | $0.04 | $0.16 |
| Revenue (latest FY) | $526.52M | $1.63B |
| Revenue growth (YoY) | +0.51% | +14.95% |
| Net income (latest FY) | $29.67M | $32.08M |
| Gross margin | 20.69% | 24.20% |
| Operating margin | 10.72% | 2.75% |
| Net margin | 5.63% | 1.97% |
| 52-week high | $20.36 | $8.16 |
| 52-week low | $7.71 | $4.79 |
| Distance from 52-week high | -61.89% | -40.93% |
| Analyst consensus | none | hold |
| Avg. price target upside | +93.30% | +36.93% |
| Average volume | 620.25K | 2.40M |
| Shares outstanding | 45.82M | 221.57M |
| Employees | 3,300 | 2,893 |
| Sector | Energy | Energy |
| Industry | Oilfield Services/Equipment | Oilfield Services/Equipment |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RPC is about 3.0 times larger than Core Laboratories by market value ($1.07B vs $355.59M).
- RES has outperformed CLB by 38.9 percentage points over the past year.
- RPC offers a meaningfully higher dividend yield (3.32% vs 0.52%).
- RPC grew revenue faster in its latest fiscal year (+14.95% vs +0.51%).
About Core Laboratories
CLB stock →Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally.
Energy · Oilfield Services/Equipment · 3,300 employees
About RPC
RES stock →RPC, Inc., together with its subsidiaries, engages provision of a range of oilfield services and equipment for the oil and gas companies involved in the exploration, production, and development of oil and gas properties. The company operates through Technical Services and Support Services segments.
Energy · Oilfield Services/Equipment · 2,893 employees
CLB vs RES FAQ
Which is bigger, Core Laboratories or RPC?
RPC (RES) is larger, with a market capitalization of $1.07B compared with $355.59M for Core Laboratories (CLB).
Which stock has performed better over the past year, CLB or RES?
RES returned -8.37% over the past 12 months, compared with -47.28% for CLB (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Core Laboratories or RPC?
RPC has the higher yield at 3.32%, compared with 0.52% for Core Laboratories.
Are Core Laboratories and RPC in the same industry?
Yes. Both are classified in the Oilfield Services/Equipment industry within the Energy sector.